Quadrature Capital Ltd lessened its stake in shares of UiPath Inc. (NYSE:PATH – Free Report) by 78.0% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 40,139 shares of the company’s stock after selling 142,390 shares during the period. Quadrature Capital Ltd’s holdings in UiPath were worth $513,000 as of its most recent filing with the SEC.
Several other large investors have also recently bought and sold shares of PATH. Senvest Management LLC increased its position in shares of UiPath by 16.7% during the 3rd quarter. Senvest Management LLC now owns 10,894,483 shares of the company’s stock worth $139,449,000 after purchasing an additional 1,559,500 shares during the last quarter. Pacer Advisors Inc. acquired a new position in UiPath during the second quarter worth $69,180,000. Jacobs Levy Equity Management Inc. raised its position in UiPath by 554.8% during the third quarter. Jacobs Levy Equity Management Inc. now owns 4,026,502 shares of the company’s stock worth $51,539,000 after acquiring an additional 3,411,562 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its stake in UiPath by 11.2% in the third quarter. Charles Schwab Investment Management Inc. now owns 2,890,360 shares of the company’s stock valued at $36,997,000 after acquiring an additional 291,171 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its position in shares of UiPath by 37.2% in the 2nd quarter. Dimensional Fund Advisors LP now owns 2,783,571 shares of the company’s stock valued at $35,296,000 after acquiring an additional 754,519 shares during the period. 62.50% of the stock is owned by institutional investors and hedge funds.
UiPath Stock Performance
Shares of NYSE PATH opened at $14.81 on Monday. The stock has a market capitalization of $8.14 billion, a P/E ratio of -92.56 and a beta of 0.94. The stock’s fifty day moving average is $13.10 and its 200 day moving average is $12.73. UiPath Inc. has a 52 week low of $10.37 and a 52 week high of $27.87.
Analysts Set New Price Targets
A number of equities research analysts have recently issued reports on PATH shares. Evercore ISI upped their target price on shares of UiPath from $13.00 to $16.00 and gave the company an “in-line” rating in a report on Friday, September 6th. DA Davidson raised their price target on UiPath from $13.00 to $15.00 and gave the company a “neutral” rating in a report on Friday, September 6th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $16.00 price objective on shares of UiPath in a report on Friday. JPMorgan Chase & Co. increased their price objective on shares of UiPath from $17.00 to $18.00 and gave the company an “overweight” rating in a research report on Friday. Finally, TD Cowen decreased their price target on shares of UiPath from $17.00 to $16.00 and set a “hold” rating on the stock in a research note on Friday, September 6th. Sixteen analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $17.71.
Get Our Latest Stock Analysis on PATH
Insider Buying and Selling
In related news, CFO Ashim Gupta sold 47,671 shares of the company’s stock in a transaction on Friday, September 13th. The stock was sold at an average price of $12.07, for a total transaction of $575,388.97. Following the completion of the sale, the chief financial officer now directly owns 849,917 shares in the company, valued at $10,258,498.19. This represents a 5.31 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 22.37% of the stock is currently owned by company insiders.
UiPath Profile
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Recommended Stories
- Five stocks we like better than UiPath
- 3 Tickers Leading a Meme Stock Revival
- Guidewire Software Provides Long-Awaited Buying Opportunity
- How to Read Stock Charts for Beginners
- What’s Behind These 3 Recent Analyst Stock Upgrades?
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Fast-Growing Companies That Are Still Undervalued
Want to see what other hedge funds are holding PATH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UiPath Inc. (NYSE:PATH – Free Report).
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.